Cargando…

Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations

How the hepatitis C virus (HCV) core antigen (HCVcAg) assay performs in detecting recently acquired HCV infection among people living with HIV (PLWH) and HIV-negative men who have sex with men (MSM) is rarely assessed in the Asia-Pacific region. High-risk participants, including PLWH with sexually t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Hsin-Yun, Liu, Wang-Da, Wang, Chih-Wen, Wei, Yu-Ju, Lin, Kuan-Yin, Huang, Yu-Shan, Su, Li-Hsin, Chen, Yi-Ting, Liu, Wen-Chun, Su, Yi-Chin, Chen, Yea-Wen, Chuang, Yu-Chung, Lu, Po-Liang, Hung, Chien-Ching, Yu, Ming-Lung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241744/ https://www.ncbi.nlm.nih.gov/pubmed/35579445 http://dx.doi.org/10.1128/spectrum.00345-22

Ejemplares similares

Three-Stage Pooled Plasma Hepatitis C Virus RNA Testing for the Identification of Acute HCV Infections in At-Risk Populations
por: Sun, Hsin-Yun, et al.
Publicado: (2022)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Incidence of recent HCV infection among persons seeking voluntary counselling and testing for HIV and sexually transmitted infections in Taiwan
por: Su, Yi-Ching, et al.
Publicado: (2014)

Optimal Frequency of Hepatitis C Virus (HCV) RNA Testing for Detection of Acute HCV Infection Among At-risk People With Human Immunodeficiency Virus: A Multicenter Study
por: Sun, Hsin-Yun, et al.
Publicado: (2023)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection
por: Liu, Hung-Yin, et al.
Publicado: (2021)

New treatments for HCV: Perspective from Asia
por: Yu, Ming‐Lung, et al.
Publicado: (2015)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

Therapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort study
por: Huang, Chung-Feng, et al.
Publicado: (2023)

HCV core antigen plays an important role in the fight against HCV as an alternative to HCV‐RNA detection
por: Wang, Yuhan, et al.
Publicado: (2021)

Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
por: Huang, Chung-Feng, et al.
Publicado: (2021)

Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry
por: Chang, Te-Sheng, et al.
Publicado: (2023)

Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
por: Liu, Chen-Hua, et al.
Publicado: (2015)

β-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer development
por: Ling, Yue-Ming, et al.
Publicado: (2017)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

Transcriptomic Assay of CD8(+) T Cells in Treatment-Naïve HIV, HCV-Mono-Infected and HIV/HCV-Co-Infected Chinese
por: Zhao, Jin, et al.
Publicado: (2012)

A Higher Correlation of HCV Core Antigen with CD4+ T Cell Counts Compared with HCV RNA in HCV/HIV-1 Coinfected Patients
por: Shen, Tao, et al.
Publicado: (2011)

Effect of sofosbuvir-based DAAs on changes in lower-density lipoprotein in HCV patients: a systematic review and meta-analysis
por: Wang, Ying-Wen, et al.
Publicado: (2021)

A reliable multiplex genotyping assay for HCV using a suspension bead array
por: Yang, Yi-Chen, et al.
Publicado: (2015)

Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China
por: Tan, Yi, et al.
Publicado: (2008)

HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes
por: Wang, Yizhong, et al.
Publicado: (2015)

Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy
por: Huang, Chung-Feng, et al.
Publicado: (2016)

Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study
por: Lin, Shih-Yi, et al.
Publicado: (2017)

A people-centered decentralized outreach model toward HCV micro-elimination in hyperendemic areas: COMPACT study in SARS Co–V2 pandemic
por: Huang, Ching-I, et al.
Publicado: (2023)

Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT
por: CHEN, MING-HO, et al.
Publicado: (2012)

Calcitriol Inhibits HCV Infection via Blockade of Activation of PPAR and Interference with Endoplasmic Reticulum-Associated Degradation
por: Lin, Yu-Min, et al.
Publicado: (2018)

Village-to-village screening for hepatitis B and C using quantitative HBsAg and anti-HCV testing with reflex HCV core antigen tests in the remote communities of a resource-rich setting: a population-based prospective cohort study
por: Chang, Te-Sheng, et al.
Publicado: (2021)

Attenuation of 40S Ribosomal Subunit Abundance Differentially Affects Host and HCV Translation and Suppresses HCV Replication
por: Huang, Jing-Ying, et al.
Publicado: (2012)

Is HCV core antigen a reliable marker of viral load? An evaluation of HCV core antigen automated immunoassay
por: Hadziyannis, Emilia, et al.
Publicado: (2013)

Resistant-Associated Substitutions Do Not Affect HCV RNA and HCV Core Antigen Clearance During Direct-Acting Antiviral Agent Treatment in a Real-World Setting
por: Chen, Hongyu, et al.
Publicado: (2022)

An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA
por: Hansoongnern, Payuda, et al.
Publicado: (2023)

Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan
por: Huang, Miao-Hui, et al.
Publicado: (2021)

Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment
por: Wiesmann, F., et al.
Publicado: (2015)

Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia
por: Russi, Sabino, et al.
Publicado: (2014)

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs
por: Wasitthankasem, Rujipat, et al.
Publicado: (2017)

In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survival
por: Huang, Chien-Hao, et al.
Publicado: (2019)

Can HCV Core Ag Testing Replace the Routine Screening Assays in Patients on Hemodialysis?
por: Einollahi, Behzad, et al.
Publicado: (2014)

HCV IRES-Mediated Core Expression in Zebrafish
por: Zhao, Ye, et al.
Publicado: (2013)

Development of sandwich ELISA and lateral flow strip assays for diagnosing clinically significant snakebite in Taiwan
por: Liu, Chien-Chun, et al.
Publicado: (2018)

Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
por: Liou, Bo-Huang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4asdhrjfshgu43vq296sm94o3v